We defined candidate proteins with significant differential expression (p < 0.05 by Student’s t test) as those with a fold change of at least 1.2 between FBXL6-induced HCC tumors and adjacent tissues. This evidence concerns the gene FBXL6 and hepatocellular carcinoma.